Status:

COMPLETED

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Lead Sponsor:

Pfizer

Conditions:

Growth Disorder

Eligibility:

All Genders

Phase:

PHASE3

Brief Summary

This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age

Eligibility Criteria

Inclusion

  • Participation in the 90-080 study

Exclusion

  • Any severe, acute or chronic disease
  • Any other identifiable reason for short stature

Key Trial Info

Start Date :

April 1 2001

Trial Type :

INTERVENTIONAL

End Date :

August 1 2005

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT00174421

Start Date

April 1 2001

End Date

August 1 2005

Last Update

May 3 2007

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.